Since increased VEGF expression is significantly associated with advanced-stage thyroid cancer [29], the use of inhibitors against VEGFR2 signaling pathway may represent a viable approach to controlling malignant thyroid cancer [30]. The gene discussed is VEGFA; the disease is thyroid gland carcinoma.